![Andrew P. Savadelis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew P. Savadelis
No open positions remaining
Profile
Andrew P.
Savadelis formerly worked at Tamir Biotechnology, Inc., as Director, II-VI OptoElectronic Devices, Inc., as Director-Investor Relations & Treasurer, Bristol Myers Squibb Co., as Treasurer & Manager-Corporate Treasury, eMagin Corp., as Chief Financial Officer & Executive Vice President, Orchid Cellmark, Inc., as Chief Financial Officer & Senior Vice President, NanoOpto Corp., as Chief Financial Officer from 2005 to 2007, LUMEnergi, Inc., as Chief Financial Officer from 2012 to 2013, and Angion Biomedica Corp., as Chief Financial Officer.
Mr. Savadelis received his undergraduate degree from Albright College and Masters Business Admin degree from Cornell University.
Former positions of Andrew P. Savadelis
| Companies | Position | End |
|---|---|---|
LUMEnergi, Inc.
 LUMEnergi, Inc. Electrical ProductsProducer Manufacturing Manufactures lighting equipment | Director of Finance/CFO | 01/04/2013 |
NanoOpto Corp.
 NanoOpto Corp. SemiconductorsElectronic Technology Manufactures nanoscale optical components | Director of Finance/CFO | 01/01/2007 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Director/Board Member | 06/12/2005 |
| ANGN BIOM | Director of Finance/CFO | - |
| BRISTOL-MYERS SQUIBB COMPANY | Treasurer | - |
Training of Andrew P. Savadelis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
II-VI OptoElectronic Devices, Inc.
 II-VI OptoElectronic Devices, Inc. Electronic Production EquipmentElectronic Technology Manufactures radio frequency integrated circuits | Electronic Technology |
eMagin Corp.
 eMagin Corp. Computer PeripheralsElectronic Technology Manufactures OLED micro displays | Electronic Technology |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
NanoOpto Corp.
NanoOpto Corp. SemiconductorsElectronic Technology Manufactures nanoscale optical components | Electronic Technology |
Albright College
 Albright College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LUMEnergi, Inc.
LUMEnergi, Inc. Electrical ProductsProducer Manufacturing Manufactures lighting equipment | Producer Manufacturing |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Andrew P. Savadelis
